Amalgamated Bank’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $619K | Buy |
5,446
+86
| +2% | +$9.78K | ﹤0.01% | 1209 |
|
|
2025
Q1 | $564K | Sell |
5,360
-166
| -3% | -$17.5K | ﹤0.01% | 1214 |
|
|
2024
Q4 | $592K | Buy |
5,526
+177
| +3% | +$19K | ﹤0.01% | 1244 |
|
|
2024
Q3 | $535K | Buy |
5,349
+191
| +4% | +$19.1K | ﹤0.01% | 1276 |
|
|
2024
Q2 | $435K | Sell |
5,158
-148
| -3% | -$12.5K | ﹤0.01% | 1352 |
|
|
2024
Q1 | $388K | Sell |
5,306
-988
| -16% | -$72.2K | ﹤0.01% | 1407 |
|
|
2023
Q4 | $450K | Sell |
6,294
-155
| -2% | -$11.1K | ﹤0.01% | 1485 |
|
|
2023
Q3 | $386K | Sell |
6,449
-241
| -4% | -$14.4K | ﹤0.01% | 1535 |
|
|
2023
Q2 | $482K | Buy |
6,690
+12
| +0.2% | +$865 | ﹤0.01% | 1453 |
|
|
2023
Q1 | $491K | Sell |
6,678
-522
| -7% | -$38.4K | ﹤0.01% | 1433 |
|
|
2022
Q4 | $481K | Sell |
7,200
-4,342
| -38% | -$290K | ﹤0.01% | 1485 |
|
|
2022
Q3 | $620K | Sell |
11,542
-346
| -3% | -$18.6K | 0.01% | 1328 |
|
|
2022
Q2 | $662K | Buy |
11,888
+74
| +0.6% | +$4.12K | 0.01% | 1328 |
|
|
2022
Q1 | $829K | Sell |
11,814
-620
| -5% | -$43.5K | 0.01% | 1301 |
|
|
2021
Q4 | $1.2M | Sell |
12,434
-218
| -2% | -$21K | 0.01% | 1159 |
|
|
2021
Q3 | $1.1M | Sell |
12,652
-6,794
| -35% | -$591K | 0.01% | 1202 |
|
|
2021
Q2 | $1.59M | Buy |
19,446
+15,929
| +453% | +$1.3M | 0.01% | 1062 |
|
|
2021
Q1 | $334K | Sell |
3,517
-322
| -8% | -$30.6K | 0.01% | 1211 |
|
|
2020
Q4 | $238K | Buy |
3,839
+38
| +1% | +$2.36K | 0.01% | 1355 |
|
|
2020
Q3 | $226K | Sell |
3,801
-125
| -3% | -$7.43K | 0.01% | 1263 |
|
|
2020
Q2 | $274K | Sell |
3,926
-647
| -14% | -$45.2K | 0.01% | 1162 |
|
|
2020
Q1 | $207K | Sell |
4,573
-141
| -3% | -$6.38K | 0.01% | 1350 |
|
|
2019
Q4 | $307K | Sell |
4,714
-198
| -4% | -$12.9K | 0.01% | 1396 |
|
|
2019
Q3 | $305K | Sell |
4,912
-94
| -2% | -$5.84K | 0.01% | 1314 |
|
|
2019
Q2 | $356K | Sell |
5,006
-414
| -8% | -$29.4K | 0.01% | 1252 |
|
|
2019
Q1 | $425K | Buy |
5,420
+169
| +3% | +$13.3K | 0.01% | 1081 |
|
|
2018
Q4 | $445K | Buy |
5,251
+2,928
| +126% | +$248K | 0.01% | 984 |
|
|
2018
Q3 | $398K | Sell |
2,323
-3,154
| -58% | -$540K | 0.01% | 1023 |
|
|
2018
Q2 | $708K | Buy |
5,477
+734
| +15% | +$94.9K | 0.02% | 870 |
|
|
2018
Q1 | $489K | Sell |
4,743
-79
| -2% | -$8.15K | 0.01% | 968 |
|
|
2017
Q4 | $412K | Buy |
4,822
+298
| +7% | +$25.5K | 0.01% | 1091 |
|
|
2017
Q3 | $384K | Buy |
4,524
+16
| +0.4% | +$1.36K | 0.01% | 1068 |
|
|
2017
Q2 | $341K | Buy |
4,508
+468
| +12% | +$35.4K | 0.01% | 1124 |
|
|
2017
Q1 | $267K | Sell |
4,040
-8
| -0.2% | -$529 | 0.01% | 1214 |
|
|
2016
Q4 | $257K | Buy |
4,048
+525
| +15% | +$33.3K | 0.01% | 1236 |
|
|
2016
Q3 | $224K | Buy |
3,523
+12
| +0.3% | +$763 | 0.01% | 1196 |
|
|
2016
Q2 | $251K | Buy |
+3,511
| New | +$251K | 0.01% | 1123 |
|